Cargando…

Similarities and differences between stakeholders’ opinions on using Health Technology Assessment (HTA) information across five European countries: results from the EQUIPT survey

BACKGROUND: The European-study on Quantifying Utility of Investment in Protection from Tobacco (EQUIPT) project aimed to study transferability of economic evidence by co-creating the Tobacco Return On Investment (ROI) tool, previously developed in the United Kingdom, for four sample countries (Germa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Vokó, Zoltan, Cheung, Kei Long, Józwiak-Hagymásy, Judit, Wolfenstetter, Silke, Jones, Teresa, Muñoz, Celia, Evers, Silvia M.A.A., Hiligsmann, Mickaël, de Vries, Hein, Pokhrel, Subhash
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2016
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4882811/ https://www.ncbi.nlm.nih.gov/pubmed/27230485 http://dx.doi.org/10.1186/s12961-016-0110-7

Ejemplares similares

EQUIPT: protocol of a comparative effectiveness research study evaluating cross-context transferability of economic evidence on tobacco control
por: Pokhrel, Subhash, et al.
Publicado: (2014)

Estimates of costs for modelling return on investment from smoking cessation interventions
por: Trapero‐Bertran, Marta, et al.
Publicado: (2018)

Understanding perceived availability and importance of tobacco control interventions to inform European adoption of a UK economic model: a cross-sectional study
por: Kulchaitanaroaj, Puttarin, et al.
Publicado: (2018)

Cost‐effectiveness of possible future smoking cessation strategies in Hungary: results from the EQUIPTMOD
por: Németh, Bertalan, et al.
Publicado: (2018)

A utility of model input uncertainty analysis in transferring tobacco control‐related economic evidence to countries with scarce resources: results from the EQUIPT study
por: Németh, Bertalan, et al.
Publicado: (2018)

Assessment of cost‐effective changes to the current and potential provision of smoking cessation services: an analysis based on the EQUIPTMOD
por: Anraad, Charlotte, et al.
Publicado: (2018)

Is it cost‐effective to provide internet‐based interventions to complement the current provision of smoking cessation services in the Netherlands? An analysis based on the EQUIPTMOD
por: Cheung, Kei‐Long, et al.
Publicado: (2017)

Model‐based economic evaluations in smoking cessation and their transferability to new contexts: a systematic review
por: Berg, Marrit L., et al.
Publicado: (2017)

Exploring consensus on how to measure smoking cessation. A Delphi study
por: Cheung, Kei Long, et al.
Publicado: (2017)

The implementation of HTA in medicine pricing and reimbursement policies in Indonesia: Insights from multiple stakeholders
por: Wasir, Riswandy, et al.
Publicado: (2019)

Using qualitative research to facilitate the interpretation of quantitative results from a discrete choice experiment: insights from a survey in elderly ophthalmologic patients
por: Vennedey, Vera, et al.
Publicado: (2016)

The role of stakeholder involvement in the evolving EU HTA process: Insights generated through the European Access Academy’s multi-stakeholder pre-convention questionnaire
por: Van Haesendonck, Lauren, et al.
Publicado: (2023)

Expanding HTA – Correcting a Misattribution, Clarifying the Scope of HTA and CEA: Comment on "Ethics in HTA: Examining the ‘Need for Expansion’"
por: Culyer, Anthony J.
Publicado: (2019)

Navigating HTA implementation: a review of Indonesia’s revised HTA guideline
por: Chavarina, Kinanti Khansa, et al.
Publicado: (2023)

Cost-Effectiveness and Cost-Utility of Internet-Based Computer Tailoring for Smoking Cessation
por: Smit, Eline Suzanne, et al.
Publicado: (2013)

GMS-HTA: Information out of the world of HTA - up-to-date, comprehensive and valid
por: Rüther, Alric
Publicado: (2005)

HTA Implementation Roadmap in Central and Eastern European Countries
por: Kaló, Zoltán, et al.
Publicado: (2016)

Varying Opinions on Who Deserves Collectively Financed Health Care Services: A Discrete Choice Experiment on Allocation Preferences of the General Public
por: van der Aa, Maartje J., et al.
Publicado: (2018)

HTA Training for Healthcare Professionals: International Overview of Initiatives Provided by HTA Agencies and Organizations
por: Hoxhaj, Ilda, et al.
Publicado: (2022)

The Impact of Brexit on Pharmaceuticals and HTA
por: Lorgelly, Paula K
Publicado: (2018)

Adherence to Web-Based Self-Assessments in Long-Term Direct-to-Patient Research: Two-Year Study of Multiple Sclerosis Patients
por: Jongen, Peter Joseph, et al.
Publicado: (2017)

Towards a more transparent HTA process in Poland: new Polish HTA methodological guidelines
por: Lach, Krzysztof, et al.
Publicado: (2017)

HTA and National Immunisation Program: an overview of competent bodies and of the impact of HTA on the decision-making process
por: Ricciardi, W
Publicado: (2022)

Replication of Published Health Economic Obesity Models: Assessment of Facilitators, Hurdles and Reproduction Success
por: Schwander, Björn, et al.
Publicado: (2021)

Repetitive transcranial magnetic stimulation may be a cost-effective alternative to antidepressant therapy after two treatment failures in patients with major depressive disorder
por: Zemplényi, Antal, et al.
Publicado: (2022)

HTA26 Health Technology Assessment (HTA) Methods for Monoclonal Antibodies for Treatment and Prevention of COVID-19
por: Warttig, S, et al.
Publicado: (2022)

HTA253 Payer Perspectives on the Impact of the COVID-19 Pandemic on Health Technology Assessments (HTA) in Europe
por: Hutcheson, R, et al.
Publicado: (2022)

Stakeholders’ opinions on the implementation of Child Death Review in the Netherlands
por: Gijzen, Sandra, et al.
Publicado: (2016)

A Digital Innovation for the Personalized Management of Adherence: Analysis of Strengths, Weaknesses, Opportunities, and Threats
por: Hein, Anna-Elisa, et al.
Publicado: (2020)

Use of Surrogate end points in HTA
por: Mangiapane, Sandra, et al.
Publicado: (2009)

Ethics in HTA: Examining the "Need for Expansion"
por: Abrishami, Payam, et al.
Publicado: (2017)

Impact of COVID-19 pandemic on HTA
Publicado: (2020)

Stakeholders’ perception on including broader economic impact of vaccines in economic evaluations in low and middle income countries: a mixed methods study
por: van der Putten, Ingeborg M, et al.
Publicado: (2015)

Development and application of an economic model (EQUIPTMOD) to assess the impact of smoking cessation
por: Coyle, Kathryn, et al.
Publicado: (2017)

Does the Structure Matter? An External Validation and Health Economic Results Comparison of Event Simulation Approaches in Severe Obesity
por: Schwander, Björn, et al.
Publicado: (2022)

How can the results of Health Technology Assessment (HTA) evaluations applied to vaccinations be communicated to decision-makers and stakeholders? The ISPOR Rome Chapter Project
por: GASPARINI, R., et al.
Publicado: (2015)

Value drivers for pharmaceutical products in health technology assessment (HTA) in Saudi Arabia: Results from a capacity Building, Multi-Stakeholder workshop
por: Al-Omar, Hussain A., et al.
Publicado: (2021)

How aligned are the perspectives of EU regulators and HTA bodies? A comparative analysis of regulatory‐HTA parallel scientific advice
por: Tafuri, Giovanni, et al.
Publicado: (2016)

Using Real-World Data in Health Technology Assessment (HTA) Practice: A Comparative Study of Five HTA Agencies
por: Makady, Amr, et al.
Publicado: (2017)

Towards compatibility of EUnetHTA JCA methodology and German HTA: a systematic comparison and recommendations from an industry perspective
por: Kisser, Agnes, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_drb4b7agdvb229a7k3lfij9di6